[Congressional Bills 110th Congress]
[From the U.S. Government Publishing Office]
[S. 668 Introduced in Senate (IS)]







110th CONGRESS
  1st Session
                                 S. 668

To require the Food and Drug Administration to conduct consumer testing 
 to determine the appropriateness of the current labeling requirements 
  for indoor tanning devices and determine whether such requirements 
 provide sufficient information to consumers regarding the risks that 
the use of such devices pose for the development of irreversible damage 
      to the skin, including skin cancer, and for other purposes.


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

                           February 16, 2007

 Mr. Reed (for himself and Mr. Isakson) introduced the following bill; 
     which was read twice and referred to the Committee on Health, 
                     Education, Labor, and Pensions

_______________________________________________________________________

                                 A BILL


 
To require the Food and Drug Administration to conduct consumer testing 
 to determine the appropriateness of the current labeling requirements 
  for indoor tanning devices and determine whether such requirements 
 provide sufficient information to consumers regarding the risks that 
the use of such devices pose for the development of irreversible damage 
      to the skin, including skin cancer, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Tanning Accountability and 
Notification Act of 2007''.

SEC. 2. REPORT BY FOOD AND DRUG ADMINISTRATION REGARDING LABELING 
              INFORMATION ON RELATIONSHIP BETWEEN USE OF INDOOR TANNING 
              DEVICES AND DEVELOPMENT OF SKIN CANCER OR OTHER SKIN 
              DAMAGE.

    (a) In General.--The Secretary of Health and Human Services 
(referred to in this section as the ``Secretary''), acting through the 
Commissioner of Food and Drugs, shall determine--
            (1) whether the labeling requirements for indoor tanning 
        devices, including the positioning requirements, provide 
        sufficient information to consumers regarding the risks that 
        the use of such devices pose for the development of 
        irreversible damage to the eyes and skin, including skin 
        cancer; and
            (2)(A) whether adding the warning suggested by the American 
        Academy of Dermatology to the current warning label, or any 
        other additional warning, would communicate the risks of indoor 
        tanning more effectively; or
            (B) whether there is no warning that would be capable of 
        adequately communicating such risks.
    (b) Consumer Testing.--In making the determinations under 
subsection (a), the Secretary shall conduct appropriate consumer 
testing, using the best available methods for determining consumer 
understanding of label warnings.
    (c) Public Hearings; Public Comment.--The Secretary shall hold 
public hearings and solicit comments from the public in making the 
determinations under subsection (a).
    (d) Report.--Not later than 1 year after the date of the enactment 
of this Act, the Secretary shall submit to the Congress a report that 
provides the determinations under subsection (a). In addition, the 
Secretary shall include in the report the measures being implemented by 
the Secretary to significantly reduce the risks associated with indoor 
tanning devices.
                                 <all>